A farnesyltransferase inhibitor attenuated β-adrenergic receptor downregulation in rat skeletal muscle

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 282, Issue 1 51-1, 2002, Pages

  Lavoie, Julie L ^a   Calderone, Angelino ^a,b   Béliveau, Louise ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Cardiac fibroblasts; Clenbuterol; Farnesylation; Homologous desensitization; Sympathetic system

Indexed keywords

BETA ADRENERGIC RECEPTOR; BMS 191563; CLENBUTEROL; ISOPRENALINE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FIBROBLAST; GASTROCNEMIUS MUSCLE; HEART MUSCLE CELL; INHIBITION KINETICS; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE;

EID: 0036088787     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00274.2001     Document Type: Article

References (33)

1. 2-adrenergic receptor
2. Subtype-specific regulation of the β-adrenergic receptors
3. A farnesyltransferase inhibitor attenuates cardiac myocyte hypertrophy and gene expression
4. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts
5. G protein-coupled receptors: Heterologous regulation of homologous desensitization and its implications
6. β-Adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase
7. Receptor and G β-γ isoform-specific interactions with G protein-coupled receptor knases
8. Pre- and postsynaptic adrenergic dysfunctions in hypertension
9. C-terminal motifs found in Ras-superfamily G-proteins: CAAX and C-seven motifs
10. G-protein-coupled receptor kinases and arrestins: Regulators of G-protein -coupled receptor sequestration
11. Phosphorylation and desensitization of the human β-adrenergic receptor: Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase
12. 2-adrenergic receptor
13. Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic
14. Isoprenylation of a protein kinase: Requirement of farnesylation/alpha-carboxyl methylation for full enzymatic activity of rhodopsin kinase
15. β-adrenergic agonists and hypertrophy of skeletal muscles
16. 2-adrenoceptors in rat skeletal muscles
17. Farnesyltransferase inhibitors: A new class of cancer chemotherapeutics
18. Molecular mechanisms of membrane receptor desensitization
19. Beta-adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium
20. Specific Isoprenyl group linked to transducin γ-subunit is a determinant of its unique signaling properties among G-proteins
21. Clenbuterol has a greater effect on untrained than previously trained skeletal muscle
22. Chronic β-blockade increases skeletal muscle β-adrenergic-receptor density and enhances contractile force
23. Contribution of Ras GTPase/MAP kinase and cytochrome p450 metabolites to deoxycorticosterone-salt-induced hypertension
24. Role of isoprenoid lipids on the heterotrimeric G protein γ subunit in determining effector activation
25. Pleckstrin homology domain-mediated membrane association and activation of the beta-adrenergic receptor kinase requires coordinate interaction with G beta gamma subunits and lipid
26. Isolation of cDNA clones encoding eight different human G protein gamma subunits, including three novel forms designated gamma 4, gamma 10, and gamma 11 subunits
27. 125I-cyanopindolol binding sites in the rat soleus muscle
28. Direct demonstration of geranylgeranylation and farnesylation of Ki-ras in vivo
29. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy
30. Farnesyltransferase inhibitors block the neurofibromatosis type I (NFI) malignant phenotype
31. Characterization of Ha-ras, N-ras, Ki-ras4a, and Ki-ras 4b as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type 1
32. Cellular trafficking of G protein-coupled receptor/β-arrestin endocytic complexes